Trade

Alkem Laboratories share price

Balanced risk
  • 26%Low risk
  • 26%Moderate risk
  • 26%Balanced risk
  • 26%High risk
  • 26%Extreme risk
  • ₹5,469.00(-0.05%)
    May 19, 2026 15:29:24 PM IST
    • NSE
    • BSE
  • Vol : 109.30 K (NSE + BSE)
    Last 20 day avg : 108.19 K

Alkem Laboratories is trading -0.05% lower at Rs 5,469.00 as compared to its last closing price. Alkem Laboratories has been trading in the price range of 5,600.00 & 5,395.50. Alkem Laboratories has given -0.70% in this year & -2.35% in the last 5 days. Alkem Laboratories has TTM P/E ratio 27.77 as compared to the sector P/E of 25.39.There are 17 analysts who have initiated coverage on Alkem Laboratories. There are 4 analysts who have given it a strong buy rating & 4 analysts have given it a buy rating. 2 analysts have given the stock a sell rating.The company posted a net profit of 636.02 Crores in its last quarter.Listed peers of Alkem Laboratories include Divi's Laboratories (1.27%), Cipla (-1.16%), Sun Pharmaceutical Industries (-1.21%).The Mutual Fund holding in Alkem Laboratories was at 15.57% in 31 Mar 2026. The MF holding has decreased from the last quarter. The FII holding in Alkem Laboratories was at 10.15% in 31 Mar 2026. The FII holding has decreased from the last quarter.

  • Overview
  • Financials
  • Forecast
  • Technical Analysis
  • Peers
  • Shareholding
  • About the company
  • FAQ

Overview

  • 1 D
  • 5 D
  • 1 M
  • 3 M
  • 6 M
  • 1 Y
  • 5 Y
  • MAX
Explore on
Loading...
Key Metrics

Updated on May 19, 2026, 01:53 PM UTC

  • Beta
    Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
    0.80
    Low volatility
  • Debt To Equity
    The debt-to-equity ratio, indicating a company's financial leverage.
    0.12
    Higher than industry
  • Dividend Yield
    Annual dividends as a percentage of the stock price.
    0.93
    Inline with the industry
  • P/B
    The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
    5.47
    In line with historical values
  • P/E
    Price-to-earnings ratio based on trailing 12-month earnings
    27.66
    Lower than historical values
  • PEG Ratio
    The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
    2.89
    Indicates overvaluation
Price range
Day Range
Lowest
5,395.50
Highest
5,600.00
52 week range
Lowest
4,716.75
Highest
5,933.00
Alkem Laboratories News
Alkem Laboratories Peers
Return Comparison
Peers Comparison
Names
Technical ratingPrice%ChangeMarket CapP/EP/BDividend YieldDebt to Equity
Divi's Laboratories
Bullish
6,919.651.271,83,642.5678.6111.520.460.01
Cipla
Moderately Bullish
1,410.00-1.161,13,897.3522.953.870.870.81
Sun Pharmaceutical Industries
Bullish
1,882.15-1.214,51,580.1936.245.770.920.50
Torrent Pharmaceuticals
Bullish
4,457.151.431,50,849.2967.3217.10.8317.62
Dr Reddy's Laboratories
Bullish
1,333.950.191,11,509.7418.633.140.632.34
Mutual Fund Ownership
View all
Tata Nifty MidSmall Healthcare Index Fund Regular Growth
NA
  • Amount Invested (Cr.) 6.66
  • % of AUM 4.88
Motilal Oswal Nifty MidSmall Healthcare Index Fund Regular Growth
NA
  • Amount Invested (Cr.) 1.18
  • % of AUM 4.86
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Growth
NA
  • Amount Invested (Cr.) 227.10
  • % of AUM 4.12
NJ ELSS Tax Saver Scheme Regular Growth
NA
  • Amount Invested (Cr.) 10.63
  • % of AUM 3.92
LIC MF Healthcare Fund Regular Growth
NA
  • Amount Invested (Cr.) 3.17
  • % of AUM 3.76
Alkem Laboratories Corporate Actions
View all
  • Board Meetings
  • AGM
  • Dividends
  • Bonus
  • Split
  • Rights
Meeting DatePurpose
2026-02-13Quarterly Results & Interim Dividend
2025-11-13Quarterly Results
2025-08-12Quarterly Results
2025-05-29Audited Results & Final Dividend
2025-02-07Quarterly Results & Interim Dividend
About the company Alkem Laboratories
  • IndustryBiotechnology & Drugs
  • ISININE540L01014
  • BSE Code539523
  • NSE CodeALKEM
Alkem Laboratories Ltd. is an India-based pharmaceutical company engaged in the development, manufacturing, and sale of pharmaceutical products. The Company operates in a single business segment-Pharmaceuticals. It produces branded generics, generic drugs, active pharmaceutical ingredients (APIs), and nutraceuticals, which it markets in India and international markets. It has a portfolio of approximately 800 brands in India and maintains a presence in over 40 international markets, with the United States being its key focus market. Its offerings include therapies, prescription (Rx) products, and Alkem generics. Its therapy offerings cover multiple medical fields, including anti-infectives, anti-osteoporosis, cardiology, neurology, dermatology, diabetology, gastroenterology, gynecology, oncology, ophthalmology, respiratory care, rheumatology, and urology. The Company’s subsidiaries include Ascend Laboratories (Pty) Ltd, Pharmacor Pty Limited, Alkem Laboratories Corporation, and others.
  • Management Info
  • Basudeo SinghExecutive Chairman of the Board
  • Vikas GuptaChief Executive Officer
  • Nitin AgrawalPresident - Finance, Chief Financial Officer
  • Manish NarangPresident - Legal, Chief Compliance Officer, Company Secretary
  • Sandeep SinghManaging Director, Executive Director
  • Madhurima SinghExecutive Director
  • Mritunjay SinghExecutive Director
  • Sarvesh SinghExecutive Director
  • Srinivas SinghExecutive Director
Alkem Laboratories Share Price FAQs

Alkem Laboratories is trading at 5469.00 as on Tue May 19 2026 09:59:24. This is -0.05% lower as compared to its previous closing price of 5471.65.

The market capitalization of Alkem Laboratories is 65559.64 Cr as on Tue May 19 2026 09:59:24.

The average broker rating on Alkem Laboratories is Buy. The breakup of analyst rating is given below -

  • 4 analysts have given a strong buy rating
  • 4 analysts have given a buy rating
  • 7 analysts have given a hold rating
  • 2 analysts have given a sell rating
  • 0.00 analysts have given a strong sell rating

The 52 wk high for Alkem Laboratories is 5933.00 whereas the 52 wk low is 4716.75

Alkem Laboratories can be analyzed on the following key metrics -

  • TTM P/E: 27.77
  • Sector P/E: 25.39
  • Dividend Yield: 0.93%
  • D/E ratio: -

Alkem Laboratories reported a net profit of 2165.48 Cr in 2025.

The Mutual Fund Shareholding was 15.57% at the end of 31 Mar 2026.

Quick Links
EQUITY QUICK LINKS
Alkem Laboratories QUICK LINKS
FROM MARKETS
RELATED LINKS
Quarterly Results
Home/Market/Market Stats/  Alkem Laboratories share price
✕

Wait for it…

Log in to our website to save your bookmarks. It'll just take a moment.

✕

Wait for it…

Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.